All Life Group

All Life Group is a prominent Chinese biotechnology company specializing in the development and commercialization of cell-based therapies and regenerative medicine. Headquartered in Beijing, the company operates an integrated platform that encompasses large-scale cell banking, research and development of stem cell and immune cell products, and clinical translation services. Their therapeutic pipeline focuses on addressing significant unmet medical needs in chronic diseases, such as type 2 diabetes and osteoarthritis, as well as advanced oncology treatments utilizing CAR-T and NK cell platforms. All Life Group is recognized for its state-of-the-art cell processing facilities and its role in establishing industry standards for cell therapy in the region. The company maintains strategic collaborations with leading academic and medical institutions to advance its clinical programs and expand the reach of cellular medicine.